AllianceBernstein (AB)
(Delayed Data from NYSE)
$34.73 USD
+0.14 (0.40%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $34.71 -0.02 (-0.06%) 6:18 PM ET
2-Buy of 5 2
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.73 USD
+0.14 (0.40%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $34.71 -0.02 (-0.06%) 6:18 PM ET
2-Buy of 5 2
A Value C Growth B Momentum A VGM
Zacks News
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Should Value Investors Buy AllianceBernstein (AB) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
T. Rowe Price (TROW) Stock Gains 2.1% as November AUM Increases
by Zacks Equity Research
T. Rowe Price (TROW) records AUM worth $1.34 trillion for November 2022, reflecting a rise of 4.7% from the previous month.
Invesco (IVZ) November AUM Rises 5.7% on Favorable Markets
by Zacks Equity Research
Invesco (IVZ) records a 5.7% sequential rise in preliminary assets under management for November 2022.
AllianceBernstein and Societe Generale Plan to Form a JV
by Zacks Equity Research
AllianceBernstein (AB) and Societe Generale (SCGLY) decide to form a JV by combining their cash equities and equity research businesses.
T. Rowe Price (TROW) Gains 17% on October AUM Rise to $1.28T
by Zacks Equity Research
T. Rowe Price (TROW) witnesses an improvement in October AUM on the back of favorable market performance.
Lazard's (LAZ) October AUM Rises 3.4% on Market Appreciation
by Zacks Equity Research
Market appreciation and favorable FX movements aid Lazard's (LAZ) October AUM balance.
Virtus Investment (VRTS) Stock Gains 7.8% on October AUM Rise
by Zacks Equity Research
Virtus Investment (VRTS) records an AUM balance of $149.5 billion for the end of October 2022, which represents a rise of 3.1% from the end of the previous month.
Invesco (IVZ) October AUM Rises 2.8% on Favorable Markets
by Zacks Equity Research
Invesco (IVZ) records a 2.8% sequential rise in preliminary assets under management for October 2022.
AllianceBernstein (AB) Stock Up 1.7% as October AUM Rises
by Zacks Equity Research
AllianceBernstein's (AB) October AUM balance improves on the back of solid market performance.
Implied Volatility Surging for AllianceBernstein (AB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to AllianceBernstein (AB) stock based on the movements in the options market lately.
Zacks.com featured highlights include Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE
by Zacks Equity Research
Terns Pharmaceuticals, AllianceBernstein Holding and ALLETE have been highlighted in this Screen of The Week article.
3 Stocks for Higher Returns as New Analysts Initiate Coverage
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Terns Pharmaceuticals (TERN), AllianceBernstein (AB) and ALLETE (ALE).
Lazard's (LAZ) August AUM Slips 3.6% on Market Depreciation
by Zacks Equity Research
Market depreciation, unfavorable FX movements and net outflows hurt Lazard's (LAZ) August AUM balance.
Invesco's (IVZ) August AUM Down on Unfavorable Market Returns
by Zacks Equity Research
Market depreciation, unfavorable FX movements and non-management fee-earning net outflows hurt Invesco's (IVZ) August AUM balance as it falls 2.3% from the prior month.
AllianceBernstein (AB) Stock Up 2.3% as July AUM Rises 6.5%
by Zacks Equity Research
Market appreciation and the acquisition of CarVal Investors aid AllianceBernstein's (AB) July AUM balance as it rises 6.5% from the prior month.
AllianceBernstein (AB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
AllianceBernstein (AB) closed the most recent trading day at $43, moving +0.37% from the previous trading session.
AllianceBernstein (AB) Witnesses Marginal Rise in May AUM
by Zacks Equity Research
AllianceBernstein (AB) records month-end AUM of $687 billion in May 2022, up marginally from the end of the prior month.
Equitable Holdings (EQH) Cheers Investors With 11% Dividend Hike
by Zacks Equity Research
Based on the increased rate, Equitable Holdings' (EQH) annual dividend comes to 80 cents per share.
AllianceBernstein (AB) Stock Down as April AUM Declines 6.8%
by Zacks Equity Research
Dismal market performance and outflows lead to a decline in AllianceBernstein's (AB) April AUM balance.
Franklin Resources (BEN) Completes Lexington Partners Buyout
by Zacks Equity Research
Franklin (BEN) completes the acquisition of Lexington Partners L.P. in a cash deal of $1.75 billion to boost its alternative asset business.
Equitable Holdings (EQH) Arm to Acquire CarVal for $750M
by Zacks Equity Research
Equitable Holdings (EQH) expects the CarVal Investors acquisition to close in the second quarter of this year.
AllianceBernstein (AB) to Acquire CarVal Investors for $750M
by Zacks Equity Research
AllianceBernstein (AB) will strengthen private market capabilities and market position with the acquisition of CarVal, a global private alternatives investment manager, for $750 million.
AllianceBernstein (AB) February AUM Down on Unfavorable Markets
by Zacks Equity Research
AllianceBernstein's (AB) AUM balance for February declines on market depreciation, while net inflows offer some support.
AllianceBernstein (AB) January AUM Down on Market Depreciation
by Zacks Equity Research
AllianceBernstein's (AB) preliminary AUM for month-end January 2022 of $751 billion is down 3.6% from the previous month. The decline is mainly due to market depreciation.